Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.260
-0.230 (-5.12%)
Aug 12, 2025, 11:41 AM - Market open
Accolade Market Cap
Nephros has a market cap or net worth of $45.16 million as of August 12, 2025. Its market cap has increased by 93.81% in one year.
Market Cap
45.16M
Enterprise Value
43.76M
1-Year Change
93.81%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $45.16M, a decrease of -16.53%. That is a compound annual growth rate of -2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 47.60M | 207.10% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
| Aug 15, 2019 | 54.10M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |